Pacific Biosciences of California Inc (NASDAQ:PACB) shares traded -7.69% lower at $1.56 on Wall Street last session.
PACB stock price is now -6.44% away from the 50-day moving average and -65.22% away from the 200-day moving average. The market capitalization of the company currently stands at $425.15M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
, while ‘Goldman’ rates the stock as ‘Neutral’
In other news, MARK VAN OENE, Officer bought 38,011 shares of the company’s stock on Aug 16 ’24. The stock was bought for $63,189 at an average price of $1.66. An SEC document containing details of the transaction can be found on the SEC’s website. On May 20 ’24, Farmer Michele sold 5,275 shares of the business’s stock. A total of $10,708 was realized by selling the stock at an average price of $2.03. This leaves the insider owning 211,941 shares of the company worth $0.33 million. A total of 3.03% of the company’s stock is owned by insiders.
During the past 12 months, Pacific Biosciences of California Inc has had a low of $1.16 and a high of $11.95. As of last week, the company has a debt-to-equity ratio of 1.88, a current ratio of 8.01, and a quick ratio of 7.14. The fifty day moving average price for PACB is $1.658 and a two-hundred day moving average price translates $4.45785 for the stock.
The latest earnings results from Pacific Biosciences of California Inc (NASDAQ: PACB) was released for 2024-06-30. The net profit margin was -211.99% and return on equity was -70.57% for PACB. The company reported revenue of $36.01 million for the quarter, compared to $47.57 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -24.3 percent.
